Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

varicella zoster virus strain Oka/Merck live antigen

A sterile, lyophilized preparation of the Oka/Merck strain of the live, attenuated varicella zoster virus (VZV), that can be used to prevent varicella, commonly known as chickenpox, or herpes zoster (HZ), commonly known as shingles. Upon reconstitution and subcutaneous vaccination with the VZV strain Oka/Merck live antigen, this vaccine induces antigen-specific T-cell and B-cell immune responses against the VZV, thereby protecting against VZV infection.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:human herpesvirus 3 live (attenuated) antigen
varicella-zoster virus live
zoster vaccine live
US brand name:Varivax
Zostavax
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search